Innovesta Technologies

AI-based Financial Data Analysis

Fintech & Insurtech
Non Active, Jan 2024 ceased to operate

Company Overview

Snapshot

Founded in November 2016 by Yali Harari and Keren Kay, Innovesta Technologies operated with 11–50 employees. The company raised $3.75 million across two funding rounds from four investors. Innovesta Technologies ceased operations in January 2024.

Business overview

Innovesta Technologies developed an end-to-end AI-based signal factory designed to uncover correlations, optimize predictions, and reveal information about private and public companies. The company's core technology leverages artificial intelligence and machine learning to enable intelligent financial decision-making. Innovesta Technologies served the Fintech & Insurtech sector, specifically focusing on trading and investing, and offered products like Innodex and Innovesta to B2B and B2C markets in the Americas.

Strategic signal

In January 2024, Innovesta Technologies ceased operations, marking a significant shift for the company. This event indicates a complete halt in its business activities and product development, signaling to investors and the market that the company is no longer active in the Fintech & Insurtech sector.

Company Intelligence Q&A

What is Innovesta Technologies' primary business?
Innovesta Technologies develops an AI-based signal factory to uncover correlations, optimize predictions, and reveal information about private and public companies, enabling intelligent financial decision-making.
When was Innovesta Technologies founded?
Innovesta Technologies was founded in November 2016.
Who are the founders of Innovesta Technologies?
Yali Harari and Keren Kay are the co-founders of Innovesta Technologies.
What was the total capital raised by Innovesta Technologies?
Innovesta Technologies raised a total of $3.75 million across two funding rounds.
What is the current operational status of Innovesta Technologies?
Innovesta Technologies ceased to operate in January 2024 and is currently non-active.